✨ Lidocaine Hydrochloride (CAS 6108-05-0) | USP-Grade Local Anesthetic & Antiarrhythmic Agent ✨
🧪 Product Overview
Lidocaine Hydrochloride (CAS 6108-05-0), also known as Lignocaine HCl monohydrate, is a high-purity amide-class local anesthetic and antiarrhythmic drug with the molecular formula C₁₄H₂₂N₂O·HCl·H₂O and a molecular weight of 288.81. This white crystalline powder (≥99% purity) is widely used in clinical settings for rapid pain relief and cardiac arrhythmia management. It exhibits strong penetration, fast onset (5 minutes), and prolonged duration (1–1.5 hours), making it 2× more potent than procaine with lower toxicity.
Key Functions:
Induces local anesthesia for surgical and diagnostic procedures.
Stabilizes cardiac membranes to treat ventricular arrhythmias.
Serves as a reference standard in pharmaceutical quality control.
Target Industries: Pharmaceuticals, hospitals, veterinary medicine, and research labs.
⭐ Key Advantages
| 🔹 Ultra-High Purity | 🔹 Rapid Action | 🔹 Stability |
|---|
| ≥99% HPLC-certified | Onset in 5 minutes | Resistant to acid/alkali hydrolysis |
| Batch-specific COA | Duration: 1–1.5 hours | Tolerates autoclaving |
🏭 Applications
- Surgical Anesthesia
: Topical creams, injectables for minor surgeries and dental procedures.
- Cardiac Care
: Intravenous use for ventricular tachycardia and fibrillation.
- Pharmaceutical R&D
: Impurity profiling and API synthesis in drug development.
📊 Quality Assurance
- Certifications
: Complies with
USP/EP pharmacopeial standards and
ISO 9001.
- Testing
: Validated via HPLC, NMR, and FTIR.
- Packaging
: Available in
25kg bulk drums or smaller R&D batches (10mg–1kg).
📈 Market Insights
The global local anesthetics market is projected to grow at 6.1% CAGR (2025–2030), driven by increasing surgical volumes and demand for non-opioid pain management. Lidocaine remains a cornerstone in emergency medicine, with Asia-Pacific leading adoption due to expanding healthcare infrastructure and cost-effective manufacturing.
China
